Sandbox Financial Partners, LLC Bristol Myers Squibb CO Transaction History

Sandbox Financial Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$57.89 - $64.73 $73,462 - $82,142	-1,269 Reduced 22.18%	4,452 $258,000
Q2 2023 Jul 14, 2023	SELL	$63.71 - $70.74 $94,800 - $105,261	-1,488 Reduced 20.64%	5,721 $365,000
Q1 2023 Apr 21, 2023	BUY	$65.71 - $74.53 $243,586 - $276,282	3,707 Added 105.85%	7,209 $499,000
Q4 2022 Jan 25, 2023	BUY	$68.48 - $81.09 $14,038 - $16,623	205 Added 6.22%	3,502 $0
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $87 - $51,559	671 Added 25.55%	3,297 $234,000
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $190,700 - $210,027	2,626 New	2,626 $202,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Sandbox Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Sandbox Financial Partners, LLC with notifications on news.